Every 10-Q that Hawkins Inc (HWKN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HWKN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HWKN filings page.
Hawkins, Inc. reported first-quarter fiscal 2027 sales of $315.7 million, up 8% from $293.3 million a year earlier, with all three segments growing more than 5%. Gross margin compressed to 23.4% from 24.7%, reflecting higher LIFO charges and freight costs. Operating income fell 6% to $38.7 million, and net income was $28.3 million versus $29.2 million, with diluted EPS of $1.35 compared with $1.40.
Water Treatment sales rose to $158.3 million, Food & Health Sciences to $97.3 million, and Industrial Solutions to $60.1 million. Operating cash flow increased to $35.2 million, funding $11.6 million of capex and the $3.6 million Aqua-Chem acquisition. Cash was $8.0 million and debt under the $400 million Revolving Loan Facility remained $244.0 million at a 4.3% effective rate. The company paid a $0.19 per-share dividend and repurchased 45,196 shares for about $7.0 million, with 686,348 shares still available under its buyback authorization.
Hawkins, Inc. reported higher sales but slightly lower profit as it continued an acquisition-driven expansion in water treatment. For the quarter ended December 28, 2025, sales rose to $244.1 million, up from $226.2 million, while net income slipped to $14.3 million from $15.0 million as interest costs increased.
For the first nine months of fiscal 2026, sales grew 12% to $817.8 million and net income was $66.1 million, modestly below $68.0 million a year earlier. Water Treatment revenue jumped 23% to $421.0 million, helped by acquisitions, while Food & Health Sciences dipped 1% and Industrial Solutions grew 7%.
The company closed the $149.9 million WaterSurplus acquisition, plus several smaller deals, adding roughly $167.1 million in acquisition spending year-to-date. Total debt under its revolving credit facility increased to $264.0 million, lifting interest expense, but operating cash flow strengthened to $106.6 million, and shareholders’ equity rose to $518.9 million.
Hawkins, Inc. (HWKN) reported Q2 fiscal 2026 results with sales of $280.4 million, up 14% year over year, as all segments grew and Water Treatment led gains. Operating income was $33.9 million, roughly flat, while net income was $22.6 million versus $24.1 million a year ago. Diluted EPS was $1.08 versus $1.16.
Year‑to‑date, sales reached $573.7 million (up 14%) and net income was $51.8 million. SG&A rose on acquisitions, intangible amortization, and earnout accretion. Interest expense increased to $3.8 million in the quarter, reflecting higher borrowings tied to recent deals.
The company closed the WaterSurplus acquisition for approximately $149.9 million and recorded an earnout liability tied to five‑year gross profit. The revolving credit facility was expanded to $400.0 million; debt stood at $279.0 million at quarter end. Cash from operations was $71.0 million for the first half. Hawkins also realigned reporting into three segments: Water Treatment, Food & Health Sciences, and Industrial Solutions.